This report provides a comprehensive analysis of the global Continuous Glucose Monitors (CGM) market, forecasting significant growth from 2025 through 2032. Driven by a rising diabetes population and advancements in closed-loop insulin pump integration, the industry is shifting from hardware competition toward integrated data ecosystems. The study examines market dynamics across wearable and implantable types, segmented by application and geography, while profiling key industry leaders. It offers detailed insights into technological iterations, regional trends, and emerging opportunities within the evolving CGM landscape.

Market Overview

Market Size and Growth Projections

• Market Value (2025): US$ 12,157 million
• Projected Market Value (2032): US$ 19,448 million
• Compound Annual Growth Rate (CAGR): 7.4% (from 2026 to 2032)
• 2025 Production Volume: Approximately 289 million units
• Average Global Market Price: Approximately US$ 43 per unit

Product Definition

Continuous Glucose Monitors (CGM) refer to medical device systems designed to continuously measure interstitial fluid glucose levels through subcutaneous sensors. These systems transmit data to a receiving end, such as a reader or mobile application, facilitating all-weather trend monitoring and high/low blood glucose alerts.

Typical Components:

• Sensors
• Transmitters
• Display receiving ends

Functional Capabilities: Users can view current glucose values, the direction of change, and the speed of change at any time, while also reviewing trends spanning several hours to several days.

Market Dynamics

Growth Drivers

• Demographic Expansion: The growing global diabetes population.
• Clinical Demand: Rising demand among the intensive insulin treatment population for hypoglycemia risk management.
• Market Penetration: Increased adoption driven by medical insurance coverage and evolving clinical guidelines.

Technological Trends and Evolution

• Product Iteration: Evolution toward longer wearing cycles, shorter warm-up times, stronger algorithm calibration, and more robust alarm experiences.
• System-Level Competition: Acceleration of competition through the ecological binding of insulin pumps.
• Industry Shift: Transition from single-point hardware competition to comprehensive competition involving data platforms, service systems, and closed-loop ecosystems.

Economic and Competitive Factors

• Pricing Pressure: Downward pressure on the single-use cost of basic products due to scale and payment control.
• Premium Segments: High-end real-time monitoring and closed-loop linkage are expected to maintain premium pricing and higher user stickiness due to significant clinical benefits.

Report Scope and Methodology

Research Overview

Produced by LP Information, Inc. (LPI), the “Continuous Glucose Monitors Industry Forecast” provides a comprehensive analysis of past and projected sales. The report evaluates the global landscape, highlighting key trends in product segmentation, company formation, revenue, market share, latest developments, and M&A activity.

Strategic Analysis

The report analyzes the strategies of leading global companies, focusing on:

• Continuous Glucose Monitors portfolios and capabilities
• Market entry strategies
• Market positions
• Geographic footprints

Methodology

The study utilizes a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs to provide a nuanced view of the current state and future trajectory of the industry.

Market Segmentation

By Type

• Wearable
• Implantable

By Reading Method

• Real-Time
• Intermittent Scanning

By Application

• Child
• Adult
• Elderly

By Geography

• Americas: United States, Canada, Mexico, Brazil
• APAC: China, Japan, Korea, Southeast Asia, India, Australia
• Europe: Germany, France, UK, Italy, Russia
• Middle East & Africa: Egypt, South Africa, Israel, Turkey, GCC Countries

Competitive Landscape

Key Vendors

The following companies have been profiled based on primary expert input and analysis of company coverage, product portfolios, and market penetration:

• Abbott
• DexCom
• Medtronic
• Senseonics Holdings
• Cnoga Medical
• Huzhou Meiqi Medical Equipment
• Medtrum Technologies
• MicroTech Medical
• Zhejiang POCTech Corporation
• SiBionics
• Sinocare

Key Questions Addressed

• What is the 10-year outlook for the global Continuous Glucose Monitors market?
• What factors are driving Continuous Glucose Monitors market growth, globally and by region?
• Which technologies are poised for the fastest growth by market and region?
• How do Continuous Glucose Monitors market opportunities vary by end market size?
• How do Continuous Glucose Monitors break out by Type and by Application?

• 1 Scope of the Report

  • 1.1 Market Introduction

  • 1.2 Years Considered

  • 1.3 Research Objectives

  • 1.4 Market Research Methodology

  • 1.5 Research Process and Data Source

  • 1.6 Economic Indicators

  • 1.7 Currency Considered

  • 1.8 Market Estimation Caveats

• 2 Executive Summary

  • 2.1 World Market Overview

    • 2.1.1 Global Continuous Glucose Monitors Annual Sales 2021-2032

    • 2.1.2 World Current & Future Analysis for Continuous Glucose Monitors by Geographic Region, 2021, 2025 & 2032

    • 2.1.3 World Current & Future Analysis for Continuous Glucose Monitors by Country/Region, 2021, 2025 & 2032

  • 2.2 Continuous Glucose Monitors Segment by Type

    • 2.2.1 Wearable

    • 2.2.2 Implantable

    • 2.2.3 Continuous Glucose Monitors Sales by Type

      • 2.2.3.1 Global Continuous Glucose Monitors Sales Market Share by Type (2021-2026)
      • 2.2.3.2 Global Continuous Glucose Monitors Revenue and Market Share by Type (2021-2026)
      • 2.2.3.3 Global Continuous Glucose Monitors Sale Price by Type (2021-2026)

  • 2.3 Continuous Glucose Monitors Segment by Reading Method

    • 2.3.1 Real-Time

    • 2.3.2 Intermittent Scanning

    • 2.3.3 Continuous Glucose Monitors Sales by Reading Method

      • 2.3.3.1 Global Continuous Glucose Monitors Sales Market Share by Reading Method (2021-2026)
      • 2.3.3.2 Global Continuous Glucose Monitors Revenue and Market Share by Reading Method (2021-2026)
      • 2.3.3.3 Global Continuous Glucose Monitors Sale Price by Reading Method (2021-2026)

  • 2.4 Continuous Glucose Monitors Segment by Application

    • 2.4.1 Child

    • 2.4.2 Adult

    • 2.4.3 Elderly

    • 2.4.4 Continuous Glucose Monitors Sales by Application

      • 2.4.4.1 Global Continuous Glucose Monitors Sale Market Share by Application (2021-2026)
      • 2.4.4.2 Global Continuous Glucose Monitors Revenue and Market Share by Application (2021-2026)
      • 2.4.4.3 Global Continuous Glucose Monitors Sale Price by Application (2021-2026)

• 3 Global by Company

  • 3.1 Global Continuous Glucose Monitors Breakdown Data by Company

    • 3.1.1 Global Continuous Glucose Monitors Annual Sales by Company (2021-2026)

    • 3.1.2 Global Continuous Glucose Monitors Sales Market Share by Company (2021-2026)

  • 3.2 Global Continuous Glucose Monitors Annual Revenue by Company (2021-2026)

    • 3.2.1 Global Continuous Glucose Monitors Revenue by Company (2021-2026)

    • 3.2.2 Global Continuous Glucose Monitors Revenue Market Share by Company (2021-2026)

  • 3.3 Global Continuous Glucose Monitors Sale Price by Company

  • 3.4 Key Manufacturers Continuous Glucose Monitors Producing Area Distribution, Sales Area, Product Type

    • 3.4.1 Key Manufacturers Continuous Glucose Monitors Product Location Distribution

    • 3.4.2 Players Continuous Glucose Monitors Products Offered

  • 3.5 Market Concentration Rate Analysis

    • 3.5.1 Competition Landscape Analysis

    • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)

  • 3.6 New Products and Potential Entrants

  • 3.7 Market M&A Activity & Strategy

• 4 World Historic Review for Continuous Glucose Monitors by Geographic Region

  • 4.1 World Historic Continuous Glucose Monitors Market Size by Geographic Region (2021-2026)

    • 4.1.1 Global Continuous Glucose Monitors Annual Sales by Geographic Region (2021-2026)

    • 4.1.2 Global Continuous Glucose Monitors Annual Revenue by Geographic Region (2021-2026)

  • 4.2 World Historic Continuous Glucose Monitors Market Size by Country/Region (2021-2026)

    • 4.2.1 Global Continuous Glucose Monitors Annual Sales by Country/Region (2021-2026)

    • 4.2.2 Global Continuous Glucose Monitors Annual Revenue by Country/Region (2021-2026)

  • 4.3 Americas Continuous Glucose Monitors Sales Growth

  • 4.4 APAC Continuous Glucose Monitors Sales Growth

  • 4.5 Europe Continuous Glucose Monitors Sales Growth

  • 4.6 Middle East & Africa Continuous Glucose Monitors Sales Growth

• 5 Americas

  • 5.1 Americas Continuous Glucose Monitors Sales by Country

    • 5.1.1 Americas Continuous Glucose Monitors Sales by Country (2021-2026)

    • 5.1.2 Americas Continuous Glucose Monitors Revenue by Country (2021-2026)

  • 5.2 Americas Continuous Glucose Monitors Sales by Type (2021-2026)

  • 5.3 Americas Continuous Glucose Monitors Sales by Application (2021-2026)

  • 5.4 United States

  • 5.5 Canada

  • 5.6 Mexico

  • 5.7 Brazil

• 6 APAC

  • 6.1 APAC Continuous Glucose Monitors Sales by Region

    • 6.1.1 APAC Continuous Glucose Monitors Sales by Region (2021-2026)

    • 6.1.2 APAC Continuous Glucose Monitors Revenue by Region (2021-2026)

  • 6.2 APAC Continuous Glucose Monitors Sales by Type (2021-2026)

  • 6.3 APAC Continuous Glucose Monitors Sales by Application (2021-2026)

  • 6.4 China

  • 6.5 Japan

  • 6.6 South Korea

  • 6.7 Southeast Asia

  • 6.8 India

  • 6.9 Australia

  • 6.10 China Taiwan

• 7 Europe

  • 7.1 Europe Continuous Glucose Monitors by Country

    • 7.1.1 Europe Continuous Glucose Monitors Sales by Country (2021-2026)

    • 7.1.2 Europe Continuous Glucose Monitors Revenue by Country (2021-2026)

  • 7.2 Europe Continuous Glucose Monitors Sales by Type (2021-2026)

  • 7.3 Europe Continuous Glucose Monitors Sales by Application (2021-2026)

  • 7.4 Germany

  • 7.5 France

  • 7.6 UK

  • 7.7 Italy

  • 7.8 Russia

• 8 Middle East & Africa

  • 8.1 Middle East & Africa Continuous Glucose Monitors by Country

    • 8.1.1 Middle East & Africa Continuous Glucose Monitors Sales by Country (2021-2026)

    • 8.1.2 Middle East & Africa Continuous Glucose Monitors Revenue by Country (2021-2026)

  • 8.2 Middle East & Africa Continuous Glucose Monitors Sales by Type (2021-2026)

  • 8.3 Middle East & Africa Continuous Glucose Monitors Sales by Application (2021-2026)

  • 8.4 Egypt

  • 8.5 South Africa

  • 8.6 Israel

  • 8.7 Turkey

  • 8.8 GCC Countries

• 9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities

  • 9.2 Market Challenges & Risks

  • 9.3 Industry Trends

• 10 Manufacturing Cost Structure Analysis

  • 10.1 Raw Material and Suppliers

  • 10.2 Manufacturing Cost Structure Analysis of Continuous Glucose Monitors

  • 10.3 Manufacturing Process Analysis of Continuous Glucose Monitors

  • 10.4 Industry Chain Structure of Continuous Glucose Monitors

• 11 Marketing, Distributors and Customer

  • 11.1 Sales Channel

    • 11.1.1 Direct Channels

    • 11.1.2 Indirect Channels

  • 11.2 Continuous Glucose Monitors Distributors

  • 11.3 Continuous Glucose Monitors Customer

• 12 World Forecast Review for Continuous Glucose Monitors by Geographic Region

  • 12.1 Global Continuous Glucose Monitors Market Size Forecast by Region

    • 12.1.1 Global Continuous Glucose Monitors Forecast by Region (2027-2032)

    • 12.1.2 Global Continuous Glucose Monitors Annual Revenue Forecast by Region (2027-2032)

  • 12.2 Americas Forecast by Country (2027-2032)

  • 12.3 APAC Forecast by Region (2027-2032)

  • 12.4 Europe Forecast by Country (2027-2032)

  • 12.5 Middle East & Africa Forecast by Country (2027-2032)

  • 12.6 Global Continuous Glucose Monitors Forecast by Type (2027-2032)

  • 12.7 Global Continuous Glucose Monitors Forecast by Application (2027-2032)

• 13 Key Players Analysis

  • 13.1 Abbott

    • 13.1.1 Abbott Company Information

    • 13.1.2 Abbott Continuous Glucose Monitors Product Portfolios and Specifications

    • 13.1.3 Abbott Continuous Glucose Monitors Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.1.4 Abbott Main Business Overview

    • 13.1.5 Abbott Latest Developments

  • 13.2 DexCom

    • 13.2.1 DexCom Company Information

    • 13.2.2 DexCom Continuous Glucose Monitors Product Portfolios and Specifications

    • 13.2.3 DexCom Continuous Glucose Monitors Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.2.4 DexCom Main Business Overview

    • 13.2.5 DexCom Latest Developments

  • 13.3 Medtronic

    • 13.3.1 Medtronic Company Information

    • 13.3.2 Medtronic Continuous Glucose Monitors Product Portfolios and Specifications

    • 13.3.3 Medtronic Continuous Glucose Monitors Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.3.4 Medtronic Main Business Overview

    • 13.3.5 Medtronic Latest Developments

  • 13.4 Senseonics Holdings

    • 13.4.1 Senseonics Holdings Company Information

    • 13.4.2 Senseonics Holdings Continuous Glucose Monitors Product Portfolios and Specifications

    • 13.4.3 Senseonics Holdings Continuous Glucose Monitors Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.4.4 Senseonics Holdings Main Business Overview

    • 13.4.5 Senseonics Holdings Latest Developments

  • 13.5 Cnoga Medical

    • 13.5.1 Cnoga Medical Company Information

    • 13.5.2 Cnoga Medical Continuous Glucose Monitors Product Portfolios and Specifications

    • 13.5.3 Cnoga Medical Continuous Glucose Monitors Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.5.4 Cnoga Medical Main Business Overview

    • 13.5.5 Cnoga Medical Latest Developments

  • 13.6 Huzhou Meiqi Medical Equipment

    • 13.6.1 Huzhou Meiqi Medical Equipment Company Information

    • 13.6.2 Huzhou Meiqi Medical Equipment Continuous Glucose Monitors Product Portfolios and Specifications

    • 13.6.3 Huzhou Meiqi Medical Equipment Continuous Glucose Monitors Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.6.4 Huzhou Meiqi Medical Equipment Main Business Overview

    • 13.6.5 Huzhou Meiqi Medical Equipment Latest Developments

  • 13.7 Medtrum Technologies

    • 13.7.1 Medtrum Technologies Company Information

    • 13.7.2 Medtrum Technologies Continuous Glucose Monitors Product Portfolios and Specifications

    • 13.7.3 Medtrum Technologies Continuous Glucose Monitors Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.7.4 Medtrum Technologies Main Business Overview

    • 13.7.5 Medtrum Technologies Latest Developments

  • 13.8 MicroTech Medical

    • 13.8.1 MicroTech Medical Company Information

    • 13.8.2 MicroTech Medical Continuous Glucose Monitors Product Portfolios and Specifications

    • 13.8.3 MicroTech Medical Continuous Glucose Monitors Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.8.4 MicroTech Medical Main Business Overview

    • 13.8.5 MicroTech Medical Latest Developments

  • 13.9 Zhejiang POCTech Corporation

    • 13.9.1 Zhejiang POCTech Corporation Company Information

    • 13.9.2 Zhejiang POCTech Corporation Continuous Glucose Monitors Product Portfolios and Specifications

    • 13.9.3 Zhejiang POCTech Corporation Continuous Glucose Monitors Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.9.4 Zhejiang POCTech Corporation Main Business Overview

    • 13.9.5 Zhejiang POCTech Corporation Latest Developments

  • 13.10 SiBionics

    • 13.10.1 SiBionics Company Information

    • 13.10.2 SiBionics Continuous Glucose Monitors Product Portfolios and Specifications

    • 13.10.3 SiBionics Continuous Glucose Monitors Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.10.4 SiBionics Main Business Overview

    • 13.10.5 SiBionics Latest Developments

  • 13.11 Sinocare

    • 13.11.1 Sinocare Company Information

    • 13.11.2 Sinocare Continuous Glucose Monitors Product Portfolios and Specifications

    • 13.11.3 Sinocare Continuous Glucose Monitors Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.11.4 Sinocare Main Business Overview

    • 13.11.5 Sinocare Latest Developments

• 14 Research Findings and Conclusion